|
시장보고서
상품코드
1672900
우르소데옥시콜산 시장 : 제형별, 추출 방법별, 용도별, 유통경로별, 지역별Ursodeoxycholic Acid Market, By Dosage Form, By Mode of Extraction, By Application, By Distribution Channel, By Geography |
||||||
우르소데옥시콜산 세계 시장은 2025년에는 6억 5,150만 달러, 2032년에는 13억 310만 달러에 달할 것으로 예상되며 2025년부터 2032년까지 10.4%의 연평균 성장률(CAGR)로 성장할 것으로 예상됩니다.
| 보고 범위 | 보고서 상세 내용 | ||
|---|---|---|---|
| 기준 연도 | 2024년 | 2025년 시장 규모 | 6억 5,150만 달러 |
| 실적 데이터 | 2020-2024년 | 예측 기간 | 2025-2032년 |
| 예측 기간(2025-2032년) CAGR | 10.40% | 2032년 금액 예측 | 13억 310만 달러 |
우르소데옥시콜산은 간에서 생성되는 담즙산으로 섭취한 지방의 소화 흡수를 돕습니다. 원발성 담즙성 간경변증(PBC), 담석 등 다양한 간 관련 질환의 치료에 사용됩니다. 세계 우르소데옥시콜산 시장의 성장은 간 질환의 유병률 증가와 우르소데옥시콜산의 치료 효과에 대한 인식이 높아짐에 따라 주도되고 있습니다. 시장 진출기업들은 소비자 기반을 확대하기 위해 우르소데옥시콜산의 새로운 제형과 시장 개척 형태를 개발하기 위해 연구개발에 많은 투자를 하고 있습니다.
시장 역학
우르소데옥시콜산 세계 시장 성장의 원동력은 간손상에 취약한 노인 인구 증가, 신흥국 시장의 의료비 지출 증가, PBC의 1차 선택 약물로 우르소데옥시콜산의 채택 확대 등입니다. 그러나 높은 치료 비용과 대체 치료 옵션의 존재는 시장 성장에 걸림돌이 될 수 있습니다. 특정 적응증에 대한 우르소데옥시콜산 제제의 개발과 생체 이용률을 높이기 위한 새로운 기술의 출현은 시장 참여자들에게 높은 성장 기회를 제공할 것입니다. 의약품 허가를 위한 엄격한 규제는 시장 성장을 저해하는 요인으로 작용할 수 있습니다.
본 조사의 주요 특징
세계의 우르소데옥시콜산(Ursodeoxycholic Acid) 시장에 대해 조사 분석했으며, 2024년을 기준 연도로 하여 예측 기간(2025-2032년) 시장 규모와 연평균 복합 성장률(CAGR)을 조사하여 전해드립니다.
다양한 부문에 걸친 잠재적 수익 창출 기회를 파악하고, 이 시장의 매력적인 투자 제안 매트릭스를 설명합니다.
또한 시장 성장 촉진요인, 억제요인, 기회, 신제품 출시 및 승인, 시장 동향, 지역별 전망, 주요 기업의 경쟁 전략 등에 대한 중요한 고찰을 제공합니다.
이 보고서는 기업 하이라이트, 제품 포트폴리오, 주요 하이라이트, 재무 성과, 전략 및 기타 매개 변수를 기반으로 세계 우르소데옥시콜산 시장의 주요 기업을 프로파일링합니다.
이번 조사 대상 주요 기업으로는 Dr. Falk Pharma, Daewoong Pharmaceutical, Teva Pharmaceutical, Mitsubishi Tanabe Pharma, Lannett Company 등이 있습니다.
이 보고서의 통찰력을 통해 마케팅 담당자와 기업 경영진은 향후 제품 출시, 유형화, 시장 확대, 마케팅 전략에 대한 정보에 입각한 의사결정을 내릴 수 있습니다.
우르소데옥시콜산 세계 시장 보고서는 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 시장 진출기업, 재무 분석가 등 이 산업의 다양한 이해관계자를 대상으로 합니다.
이해관계자들은 세계 우르소데옥시콜산 시장을 분석할 때 사용되는 다양한 전략 매트릭스를 통해 의사결정을 용이하게 할 수 있습니다.
목차
제1장 조사 목적과 전제조건
- 조사 목적
- 전제조건
- 약어
제2장 시장 전망
- 보고서 설명
- 시장 정의와 범위
- 주요 요약
- Coherent Opportunity Map (COM)
제3장 시장 역학, 규제, 동향 분석
- 시장 역학
- 성장 촉진요인
- 성장 억제요인
- 기회
- 영향 분석
- 시장 동향
- 규제 시나리오
- 인수와 제휴 시나리오
- 자금조달과 투자
- PEST 분석
- Porter의 Five Forces 분석
제4장 세계의 우르소데옥시콜산 시장 - 코로나바이러스(COVID-19) 팬데믹의 영향
- 전체적인 영향
- 정부 이니셔티브
- 시장에 대한 COVID-19의 영향
제5장 우르소데옥시콜산 세계 시장, 제형별, 2020-2032년,(100만 달러)
- 서론
- 고형
- 액체
제6장 우르소데옥시콜산 세계 시장, 추출 방법별, 2020-2032년,(100만 달러)
- 서론
- 합성
- 생물학적
제7장 우르소데옥시콜산 세계 시장, 용도별, 2020-2032년,(100만 달러)
- 서론
- 위장질환
- 간질환
- 낭포성 섬유증
- 기타
제8장 우르소데옥시콜산 세계 시장, 유통 채널별, 2020-2032년,(100만 달러)
- 서론
- 병원 약국
- 소매 약국
- 온라인 약국
제9장 우르소데옥시콜산 세계 시장, 지역별, 2020-2032년,(100만 달러)
- 서론
- 북미
- 라틴아메리카
- 유럽
- 아시아태평양
- 중동
- 아프리카
제10장 경쟁 구도
- 기업 개요
- Dipharma Francis Srl
- ERREGIERRE SpA
- Grindeks
- Industria Chimica Emiliana
- Mitsubishi Tanabe Pharma Corporation
- Zhongshan Belling BIoTechnology Co.
- Glenmark Pharmaceutical Limited
- Abil Chempharma Private Limited
- BIoTavia Labs Pvt Ltd
- Daewoong Bio Inc.
- PharmaZell GmbH
- Suzhou Tianlu Bio-pharmaceutical Co., Ltd.
- Dr. Falk Pharma
- Teva Pharmaceuticals
- Epic Pharma
- Lannett Company, Inc.
- Mylan NV
- Bruschettini SpA
- Impax Laboratories, Inc.
- Shanghai Pharma
제11장 애널리스트 추천 사항
- 융성과 쇠퇴
- Coherent Opportunity Map
제12장 참고 문헌과 조사 방법
- 참고 문헌
- 조사 방법
Global Ursodeoxycholic Acid Market is estimated to be valued at USD 651.5 Mn in 2025 and is expected to reach USD 1,303.1 Mn by 2032, growing at a compound annual growth rate (CAGR) of 10.4% from 2025 to 2032.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2024 | Market Size in 2025: | USD 651.5 Mn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2025 To 2032 |
| Forecast Period 2025 to 2032 CAGR: | 10.40% | 2032 Value Projection: | USD 1,303.1 Mn |
Ursodeoxycholic acid is a bile acid produced by the liver that helps in digestion and absorption of consumed fats. It is prescribed for treating various liver related conditions such as primary biliary cirrhosis (PBC) and gallstones. Global ursodeoxycholic acid market growth is driven by rising prevalence of liver diseases and increasing awareness about benefits of ursodeoxycholic acid in their treatment. The market players are investing heavily in R&D to develop new formulations and delivery forms of ursodeoxycholic acid to expand consumer base.
Market Dynamics:
Global ursodeoxycholic acid market growth is driven by rising geriatric population prone to developing liver disorders, increasing healthcare expenditure in developing nations, and growing adoption of ursodeoxycholic acid as first line therapy for PBC. However, high treatment costs and availability of alternative treatment options can hamper the market growth. Development of ursodeoxycholic acid formulations targeted towards specific indications and emergence of novel technologies for enhancing its bioavailability present high growth opportunities for market players. Stringent regulations for drug approvals can hamper the market growth.
Key features of the study:
This report provides in-depth analysis of the global ursodeoxycholic acid market, and provides market size (USD Million) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global ursodeoxycholic acid market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include Dr. Falk Pharma, Daewoong Pharmaceutical, Teva Pharmaceutical, Mitsubishi Tanabe Pharma, and Lannett Company
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
Global ursodeoxycholic acid market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global ursodeoxycholic acid market
Detailed Segmentation-
- Dosage Form Insights (Revenue, USD Mn, 2020 - 2032)
- Solid Dosage Form
- Liquid Dosage Form
- Mode of Extraction Insights (Revenue, USD Mn, 2020 - 2032)
- Synthetic
- Biological
- Application Insights (Revenue, USD Mn, 2020 - 2032)
- Gastrointestinal Disorders
- Liver Disorders
- Cystic Fibrosis
- Others
- Distribution Channel Insights (Revenue, USD Mn, 2020 - 2032)
- Hospitals and Clinics
- Retail Pharmacies
- Online Pharmacies
- Regional Insights (Revenue, USD Mn 2020 - 2032)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
- Key Players Insights
- Dipharma Francis Srl
- ERREGIERRE S.p.A.
- Grindeks
- Industria Chimica Emiliana
- Mitsubishi Tanabe Pharma Corporation
- Zhongshan Belling Biotechnology Co.
- Glenmark Pharmaceutical Limited
- Abil Chempharma Private Limited
- Biotavia Labs Pvt Ltd
- Daewoong Bio Inc.
- PharmaZell GmbH
- Suzhou Tianlu Bio-pharmaceutical Co., Ltd.
- Falk Pharma
- Teva Pharmaceuticals
- Epic Pharma
- Lannett Company, Inc.
- Mylan N.V.
- Bruschettini S.p.A.
- Impax Laboratories, Inc.
- Shanghai Pharma
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snapshot, By Dosage Form
- Market Snapshot, By Mode of Extraction
- Market Snapshot, By Application
- Market Snapshot, By Distribution Channel
- Market Snapshot, By Region
- Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Opportunities
- Impact Analysis
- Market Trends
- Key Developments
- Regulatory Scenario
- Acquisitions and Partnerships Scenario
- Funding and Investments
- PEST Analysis
- Porter's Analysis
4. Global Ursodeoxycholic Acid Market - Impact of Coronavirus (COVID-19) Pandemic
- Overall Impact
- Government Initiatives
- COVID-19 Impact on the Market
5. Global Ursodeoxycholic Acid Market, By Dosage Form, 2020 - 2032, (USD Mn)
- Overview
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Solid Dosage Form
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
- Liquid Dosage Form
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
6. Global Ursodeoxycholic Acid Market, By Mode of Extraction, 2020 - 2032, (USD Mn)
- Overview
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Synthetic
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
- Biological
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
7. Global Ursodeoxycholic Acid Market, By Application, 2020 - 2032, (USD Mn)
- Overview
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Gastrointestinal Disorders
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
- Liver Disorders
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
- Cystic Fibrosis
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
- Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
8. Global Ursodeoxycholic Acid Market, By Distribution Channel, 2020 - 2032, (USD Mn)
- Overview
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Hospital Pharmacies
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
- Retail Pharmacies
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
- Online Pharmacies
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
9. Global Ursodeoxycholic Acid Market, By Region, 2020 - 2032, (USD Mn)
- Introduction
- Market Share Analysis, By Region, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, For Region, 2021-2032
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2020 - 2032, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Mode of Extraction, 2020 - 2032, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Mn)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2020 - 2032, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Mode of Extraction, 2020 - 2032, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Mn)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2020 - 2032, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Mode of Extraction, 2020 - 2032, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Mn)
- U.K.
- Germany
- Italy
- France
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2020 - 2032, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Mode of Extraction, 2020 - 2032, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Mn)
- China
- India
- Japan
- ASEAN
- Australia
- South Korea
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2020 - 2032, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Mode of Extraction, 2020 - 2032, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Mn)
- GCC
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2020 - 2032, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Mode of Extraction, 2020 - 2032, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2020 - 2032, (USD Mn)
- North Africa
- Central Africa
- South Africa
10. Competitive Landscape
- Company Profiles
- Dipharma Francis Srl
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- ERREGIERRE S.p.A.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Grindeks
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Industria Chimica Emiliana
- Mitsubishi Tanabe Pharma Corporation
- Zhongshan Belling Biotechnology Co.
- Glenmark Pharmaceutical Limited
- Abil Chempharma Private Limited
- Biotavia Labs Pvt Ltd
- Daewoong Bio Inc.
- PharmaZell GmbH
- Suzhou Tianlu Bio-pharmaceutical Co., Ltd.
- Dr. Falk Pharma
- Teva Pharmaceuticals
- Epic Pharma
- Lannett Company, Inc.
- Mylan N.V.
- Bruschettini S.p.A.
- Impax Laboratories, Inc.
- Shanghai Pharma
- Dipharma Francis Srl
11. Analyst Recommendations
- Wheel of Fortune
- Analyst View
- Coherent Opportunity Map
12. References and Research Methodology
- References
- Research Methodology
- About us and Sales Contact
